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Abstract 
Aim To use the connectivity map, a bioinformatics approach, to identify compounds that could 
induce odontogenic differentiation of dental pulp cells (DPCs) and to experimentally validate this 
effect. A subsidiary aim was to investigate the anti-inflammatory effect of any identified 
compound.
Methodology The Gene Expression Omnibus (GEO) database was searched for microarray 
datasets assessing odontogenic differentiation of human DPCs. An odontogenic gene expression 
signature was generated by differential expression analysis. The statistical significant connectivity 
map (ssCMap) method was used to identify compounds with a highly correlating gene expression 
pattern. DPCs were treated with the compound identified and osteo/odontogenic differentiation 
was assessed by alizarin red staining, alkaline phosphatase activity and expression of 
osteo/odontogenic genes ALPL, RUNX2, COL1A1, DSPP, DMP1 and SPP1 by RT-PCR. The 
anti-inflammatory effect of the compound was assessed using an ex vivo pulpitis model and 
cytokine levels were measured with multiplex assay. Means were compared using the t- test or 
ANOVA followed by a Bonferroni post hoc -test with the level of significance set at p≤0.05. 
Results The GEO database search identified a specific gene expression signature for 
osteo/odontogenic differentiation. Analysis using the ssCMap found that acetylsalicylic acid 
(ASA)/aspirin was the drug with the strongest correlation to that gene signature. The treatment of 
DPCs with 0.05 mM ASA showed increased alkaline phosphatase activity (p<0.001), 
mineralisation (p<0.05), and increased the expression of the osteo/odontogenic genes, DMP1 
and DSPP (p<0.05). Low concentration (0.05mM) ASA reduced inflammatory cytokines IL-6 
(p<0.001), CCL21 (P<0.05) and MMP-9 (p<0.05) in an ex vivo pulpitis model. 
Conclusions Connectivity mapping, a web based informatics method, was successfully used to 
identify aspirin as a candidate drug that could modulate the differentiation of DPCs. Aspirin was 
shown to induce odontogenic differentiation in DPCs in vitro and this, together with its anti-
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Introduction
The dental pulp is populated with multipotent adult stem cells that confer capacity to regenerate 
the dentine-pulp complex following damage caused by caries and trauma (Sloan & Smith 2007). 
Vital pulp therapies including direct and indirect pulp capping offer opportunities for repair 
provided an optimal environment is created for activation, recruitment and differentiation of dental 
pulp stem cells into odontoblast-like cells to produce tertiary dentine. Traditionally, calcium 
hydroxide has been the material of choice for pulp capping but clinical long term outcomes have 
been controversial (Murray & García-Godoy 2006). The introduction of calcium silicate cements 
has resulted in improved clinical outcomes, compared to calcium hydroxide (Li et al. 2015), but 
there is still an unmet need for biologically based therapies for dentine repair and regeneration 
(Kearney et al. 2018). 
The improved understanding of the biological processes associated with pulp-dentine 
regeneration facilitated and informed research leading to the discovery of biologically based pulp 
therapies. In this regard the use of bioactive molecules, such as TGF-β, was shown to enhance 
the regenerative capacity of stem cells and subsequent dentine regeneration (Goldberg et al. 
2001, Shrestha & Kishen 2017). Other approaches that utilised biomolecules known to induce 
osteogenic effects, demonstrated successful odontogenic differentiation of dental pulp cells 
(DPCs) (Phung et al. 2017). In addition pharmacological targeting of the Wnt/ catenin signalling 
pathway, which is known to have a role in dentine repair, demonstrated dentine formation in vivo 
(Neves et al. 2017).
Bioinformatics provides a novel approach to identify compounds or molecules that could induce 
dentine formation, based on their biological functions. Gene expression connectivity mapping 
(CMap) is an innovative web-based technique to establish connections via gene expression 
profiles/signatures (www.broadinstitute.org/cmap/). The CMap uses a reference database of gene 
expression profiles representing a series of structured microarray experiments in cell lines to 
various compounds or drugs. The basic concept of the CMap is to interrogate the reference 
database with the specific gene expression signature of a disease or a biological condition. 
Theoretically, these genes may be important for the induction of the phenotype of interest, 
therefore similar alteration of gene expression by any compound or drug identified would be 
predicted to induce the same phenotype. One major application of connectivity mapping is to identify 
potential small molecules able to regulate the expression of a small number of genes (Lamb et al. 
2006, Lamb, 2007). 
CMap involves the use of a pattern-matching algorithm with a high level of resolution and 
specificity, however, it has limitations. The method has been further developed into the 
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means to control for false connections between gene signature and reference profiles (Zhang & 
Gant 2008, 2009, Musa et al. 2017). The ssCMap has been successfully applied to phenotypic 
targeting and predicting effective drugs for several diseases (Ramsey et al. 2013, Malcomson et al. 
2016).
Based on phenotypic targeting, we hypothesised that connectivity mapping could be used to 
identify compounds or drugs that could shift undifferentiated DPCs towards an odontogenic 
phenotype. The aim of this study was to use publicly available gene expression datasets, 
together with ssCMap to identify compounds or drugs, already licensed for use in humans that 
could potentially induce osteo/odontogenic differentiation of DPCs and experimentally validate the 
effects in vitro. A subsidiary aim was to investigate the anti-inflammatory effect of identified 
compounds against cytokines associated with pulpitis (Rechenberg et al. 2016) using an ex vivo 
pulpitis model (Yonehiro et al. 2012, 2013).
Methods
Dataset selection
A search of the GEO database was performed using the keywords: ‘dental pulp stem cells’ 
‘DPCs,’ ‘differentiation,’ ‘lineage’ ‘osteogenesis’, ‘odontogenesis’ ‘osteogenic’ and ‘odontogenic.’ 
Datasets were assessed for inclusion in the study using the criteria: cell type, induction of 
osteo/odontogenic differentiation, and the presence of both an undifferentiated control and 
differentiated treatment group.
Connectivity mapping
The Series Matrix Files (SMF) for the selected GEO datasets contained gene expression levels 
for all the probes used in the microarrays. These were downloaded and opened in Microsoft 
Excel (Microsoft Corporation, Redmond, WA, USA). Paired t-tests were performed on the gene 
expression levels measured in undifferentiated controls and cells that had undergone 
osteogenic/odontogenic differentiation. Genes with significant (p<0.001) differential expression 
were selected and their fold change was calculated (Malcomson et al. 2016). Genes were given a 
score of +1 or -1, depending on whether they were upregulated or downregulated. 
The datasets used in this study were identified from GEO platform 6244 (GPL6244). To be 
compatible with ssCMap, the significantly differentially-expressed genes were converted to 
GPL96 probe IDs (See details in supplementary material). Connectivity mapping was carried out 
with the signature genes outlined in Table 1 using Zhang and Gant’s ssCMap (Zhang & Gant 
2009) with default settings, which included a false connection tolerance of 1.0. Compounds with a 
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of the differentially expressed genes outlined in Table 1 were analysed using Ingenuity Pathway 
Analysis (IPA) software (Qiagen, Hilden, Germany).  
Isolation and culture of DPCs
DPCs were derived by explant culture from immature permanent third molar teeth obtained in 
accordance with French ethics legislation. Cells were grown in minimal essential medium with L-
glutamine supplemented with 10% foetal bovine serum (FBS), 100UI/mL penicillin and 100μg/mL 
streptomycin and maintained in an incubator at 37C˚and 5% CO2 throughout. DPCs were seeded 
in 6-well plates at a density of 3x104/mL and treatment protocols commenced when cells were 70-
80% confluent.  Treatment protocols included, treatment with either α-MEM alone, osteogenic 
media (OM) containing 2mM β-glycerophosphate (BGP) or α-MEM supplemented with the 
predicted compound.
MTT assay
DPCs were seeded in 96-well plates at a density of 3x104/mL and treated with normal media or 
predicted compound at concentrations ranging from 0.005mM to 10mM for 3, 5 or 7 days. After 
the relevant time period 10μL MTT solution was added to each well for 2h at 37°C. Media was 
aspirated and wells air-dried for 10 minutes. Then 200μL DMSO was added and plates were 
incubated at 37°C for a further 10 minutes. Samples were mixed and absorbance was measured 
at 510nm using a Tecan GENios microplate reader. 
Alkaline phosphatase (ALP) activity assay
ALP activity of control and treated cells was assessed at 14 days. Cell lysis was performed with 
25 μL radioimmunoprecipitation assay (RIPA) buffer on ice. An alkaline phosphatase 
diethanolamine detection Kit (Sigma Aldrich, St. Louis, Missouri, USA) was employed to perform 
the assay, as previously described (Winning et al. 2017). Briefly, the assay was a 96-well plate 
format, with 5μL of each cell lysate added to 240μL of reaction buffer. Following incubation for 20 
minutes, the substrate p-nitrophenylphosphate (pNPP) was added (5μL of 0.67M pNPP solution). 
A negative control of 245μL reaction buffer with 5μL of 0.67M pNPP was also included. 
Absorbance was measured over 20 consecutive reads at 405nm.The ALP results were 
normalised to protein concentration determined using Micro BCA Protein Assay Kit (Thermo 
Fisher Scientific, Waltham, MA, USA).
Alizarin red staining
The mineralisation of treated and untreated cells was assessed with the Alizarin Red (AR) 
staining assay. Cells were fixed in ice cold 70% ethanol for 30 minutes at room temperature. 
Staining was performed with 1mL 2% AR solution (pH adjusted to 4.1-4.3 using NaOH) for 45 
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chloride in 10mM disodium hydrogen phosphate (pH 7) for 60 minutes. Absorbance was 
measured at 570nm.
Real-Time qPCR
RNA was extracted from treated and untreated cells using Qiagen RNeasy RNA Extraction Kit as 
per the manufacturer’s instructions. cDNA synthesis was carried out with SuperScript VILO cDNA 
Synthesis Kit (Thermo Fisher Scientific) using 500 ng RNA. Real-time qPCR was carried out to 
quantify osteo/odontogenic genes ALPL, RUNX2, COL1A1, DSPP, DMP-1 and SPP1. A panel of 
genes identified by differential expression analysis namely: PELI 1, ERBB3, NARS and 
RABGAP1 were also analysed. GUSB and B2M were used as reference/housekeeping genes 
(Supp Table 1). qPCR was performed using a Stratgene Mx3005P (Agilent Technologies, Santa 
Clara, CA, USA) and data was recorded by MxPro software (Agilent Technologies). The thermal 
profile consisted of an initial period of 2 minutes at 50°C and 10 minutes at 95°C, followed by 42 
cycles of 30 s at 95°C and 1 min at 60°C. For each primer a control with no template cDNA and a 
control with no reverse transcriptase were used. 
Assessment of anti-inflammatory effect of the compound in an ex vivo pulpitis model 
To assess the anti-inflammatory effect of the predicted compound, an ex vivo pulpitis model was 
established as previously described (Yonehiro et al. 2012, 2013). Briefly, DPCs and differentiated 
THP-1 cells were co-cultured in a 12-well transwell system (Corning Costar, Corning, NY, USA). 
THP-1 cells were seeded in the transwell upper chamber at the concentration of 1x105 cells per 
well. THP-1s were differentiated into macrophages by 24 h, in the presence of 150 nM phorbol 
12-myristate 13-acetate (PMA, Sigma) followed by 24 h incubation in RPMI medium. DPCs were 
seeded in the lower chamber at a concentration of 2 x105 cells per well. Cells were prepared in 
the transwells independently and just before the start of the experiments, both upper and lower 
chambers were combined as a co-culture, being separated only by a porous membrane (0.4 mm 
pore diameter). To validate the co-culture system and to confirm previous findings that cytokines 
levels differ when cells are in monolayer compared to co-culture (Yonehiro et al. 2012), a set of 
experiments were performed in which differentiated THP-1 and DPCs in monolayer and co-
culture were treated with 1μg/mL LPS for 24 h and the levels of the cytokines IL-8 and IL-B were 
measured in the cell supernatant using Duoset ELISA kits (R&D Systems, Minneapolis ,MN, 
USA).
The co cultured THP-1 macrophages and DPCs were then treated with 1μg/mL ultrapure E. coli 
LPS with or without the compound/drug of interest for 24 h. Cytokines were measured from cell 
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assay kit (R&D Systems) to simultaneously measure; IL-6, MMP-9, IL-8, CCL21, IL-1β, IFN 
gamma, angiogenin, and angiopoietin.
 To test the effect of the selected compound on the viability of differentiated THP-1 macrophages 
an MTT assay was performed as described above for DPCs, except that THP-1 cells were 
seeded at a density of 3X104 and treated with the predicted compound at a concentration of 
0.05mM for 24h. 
Statistical analysis
Data were summarised as means ± standard deviations (SD) and analysed using GraphPad 
Prism software, version 5.0 (GraphPad Software, Inc., La Jolla, CA, USA). Means were 
compared using the t- test or ANOVA followed by a Bonferroni post-test with the level of 
significance set at p≤0.05. 
Results
Connectivity mapping
The GEO database search identified an appropriate dataset (GSE44677), which was available on 
the GPL6244 platform. Differential expression analysis and conversion of probe IDs to the GPL96 
platform (as explained in supplementary material) resulted in the identification of 11 genes (Table 
1) with a role in osteo/odontogenic differentiation. These were used as the gene expression 
signature to interrogate the connectivity mapping database. The ssCMap identified 0.1mM 
acetylsalicylic acid/aspirin (ASA) as the only drug with a significant positive connection score 
(Figure 1). The connection score for ASA was 3.583, the set score was 0.262 and the p value 
was 0.0002. ASA, which is non-steroidal anti-inflammatory drug was therefore, selected for 
laboratory analysis to determine if its predicted role in osteogenic/odontogenic induction could be 
confirmed in vitro. To understand the biological function of the differentially expressed genes 
shown in Table 1, a function and pathway analysis was performed using Ingenuity Pathway 
Analysis (IPA) software. Analysis revealed the most significantly perturbed biological functions in 
the dataset to be cellular processes associated with cell morphology, development, movement, 
growth and proliferation among others (Figure 2). 
Effect of ASA on cell viability
The viability of DPCs was assessed following treatment with ASA (0.005mM to 10 mM) using the 
MTT assay. At low concentrations (< 1mM), which were suggested by the ssCMap, ASA did not 
affect the viability of DPCs or THP-1 cells, however, it was significantly affected at higher ASA 
concentrations (Figure 3. A, B, C & Supp Figure 1).
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The treatment of DPCs with either 0.05mM ASA or osteogenic media (OM) resulted in 
significantly higher (p<0.001) ALP activity than untreated cells (Figure 3 D). Similarly, Alizarin red 
staining demonstrated higher mineralisation in ASA and OM treated cells compared to cells 
treated with MEM for 14 days, p<0.001 (Figure 3E&F). There was no difference in the 
osteogenic effect between 0.05mM or 0.5mM ASA, and the lower concentration was used for the 
rest of the experiments as this approximately equates to the serum level of ASA after low dose 75 
mg aspirin treatment (Patrignani et al. 2014).
qPCR and gene expression analysis
Treatment with 0.05 mM ASA induced higher expression of the DMP1 gene compared to control 
culture after 24 h. At day 7 only the DMP1 and DSPP genes were increased compared to control, 
however, expression of the osteogenic markers RUNX2, COL1A1, SPP1 and ALPL did not 
change significantly (Figure 3 G&H).
To verify the expression of the genes identified by differential expression analysis, four were 
selected for qPCR quantification. As shown in Supp Table 2, all the genes were expressed in 
DPCs and ASA treatment modulated their expression in a way that was relatively comparable to 
their fold change shown in Table 1. 
Regulation of inflammatory cytokines with ASA
To assess if ASA at a concentration of 0.05mM exerted an anti-inflammatory effect, the level of a 
panel of cytokines previously reported as biomarkers for pulpitis (Rechenberg et al. 2016) was 
measured in an ex vivo pulpitis model using multiplex array. The production of cytokines in the 
co-culture pulpitis model was significantly higher than in THP-1 macrophages or DPCs grown as 
monolayers (Supp Figure 2). ASA treatment resulted in significant downregulation of the pro-
inflammatory cytokines IL-6, MMP-9 and CCL21, but had no significant effect on expression of 
angiogenin, angiopoietin, IL-1 β, IFN gamma and IL-8 in the ex vivo pulpitis model (Figure 4). 
Discussion
The main finding of this study was that connectivity mapping identified aspirin as a compound that 
could induce odontogenic differentiation. The gene expression signature of aspirin was shown by 
ssCMap to have the strongest correlation of any drug or compound in the reference database to 
the gene expression changes identified as occurring during osteo/odontogenic differentiation of 
DPCs. Aspirin is a prime candidate for drug repurposing due to its well-documented safety profile 
in humans. As such, the possible use of aspirin to repair damaged dentine in cases of deep 
caries and associated pulp inflammation could be particularly important. Connectivity mapping is 
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therapeutics, termed drug repurposing. The majority of previous CMap studies have focused on 
identifying whether an established drug, classically used to treat a certain disease or condition, 
shows promise in the treatment of an entirely unrelated disease or condition. For instance 
previously unrecognized analgesic and antinociceptive properties had been identified for the anti-
hypertensive drug phenoxybenzamine (Chang et al. 2010). The results of the current study 
demonstrate that connectivity mapping can be used to identify compounds that can induce the 
differentiation of DPCs. In a similar recent study, parbendazole, primarily used as an anthelmintic 
agent, was identified as an inducer of osteogenic differentiation in bone marrow derived 
mesenchymal stem cells (Brum et al. 2015). 
Support for the ability of aspirin to induce differentiation of stem cells comes from recent studies 
demonstrating osteogenic differentiation of DPCs (Yuan et al. 2018) and PDL stem cells (Abd 
Rahman et al. 2016). It was demonstrated in vitro and in vivo that aspirin, even at low 
concentrations, improved osteogenic differentiation of SHED via the (TERT)/Wnt/β-catenin 
pathway (Liu et al. 2015). In these studies the use of aspirin was not underpinned by a rationale 
that supported its choice because it was superior to any other drug but rather they were 
exploratory studies of the effects of aspirin. In the current study the connectivity mapping 
approach identified aspirin as the highest scoring drug or compound matching the gene signature 
for osteo/odontgenic differentiation.
To validate the connectivity map findings, in vitro studies were performed to confirm the 
osteo/odontogenic effect of ASA. Upregulation of the odontogenic genes DMP-1 and DSPP 
occurred as well as evidence of mineralisation in response to a low concentration of 0.05 mM 
ASA. The results, however, showed no changes in the expression of the known osteogenic genes 
RUNX2, SPP1 and COLA1. Similar findings have been reported in a study investigating the 
osteo/odontogenic differentiation of DPCs (Loison-Robert et al. 2018). DMP-1 and DSPP play 
important roles in odontoblast differentiation and dentine formation (D'Souza et al. 1997); 
however, their presence in bone and other calcified tissues makes it difficult to use them solely as 
odontoblast markers. The identification of the odontoblast-like cell phenotype remains challenging 
due to a lack of unique molecular or morphological markers (Duncan et al. 2019) and most 
studies use a panel of osteo/odontogenic genes as markers. Our results are in line with previous 
studies that demonstrated upregulation of DSPP and DMP-1 during odontoblast differentiation 
(He et al. 2008). An increase in SPP1 also occurred, but this did not reach statistical significance, 
however, since SPP1 is a late marker of osteo/odotogenic differentiation, its level may have 
increased beyond day 7 in the present study.  RUNX2 is a master regulator of osteoblast 
differentiation and although its exact role in odontogenesis is not known studies have shown that 
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(Gaikwad et al. 2001, Li et al. 2011, Widbiller et al. 2016). Therefore, the low levels of RUNX2 
gene expression observed at 7 days may indicate odontogenic, rather than osteogenic 
differentiation of DPCs. Similarly, COL1A1 gene expression was previously reported to decrease 
with time during odontogenic differentiation of DPCs treated with Biodentine (Septodont, Saint-
Maur-des-Fossés, France) (Zanini et al. 2012, Widbiller et al. 2016) and the results at 24 hours 
and 7 days are in line with this trend.
The mechanism by which ASA induces osteo/odontogenic differentiation of DPCs is not known, 
but it is likely to be downstream of the genes that have been identified by our differential 
expression analysis. The IPA analysis showed these genes to have cellular functions related to 
development, growth and proliferation, and could therefore contribute to odontogenic 
differentiation of DPCs. The genes, RABGAP1 and PEL-I, are associated with autophagy 
(Popovic et al. 2012) and the NF-kB signalling pathway (Chang et al. 2009). These pathways 
have been shown to regulate odontogenic differentiation of DPCs. Autophagy has previously 
been shown to positively regulate odontogenic differentiation of DPCs (Pei et al. 2016,Yang et al. 
2015), whereas NF-kB signalling has been reported to contribute either positively or negatively to 
this process (Feng et al. 2013, Hozhabri et al. 2015). NARS, which was also among the 
upregulated genes, is an important mediator of the effect of fibroblast growth factor on bone 
formation, by enhancing osteoblast survival and proliferation (Park et al. 2009). Among the genes 
identified as downregulated by the differential expression analysis was ERBB3, a receptor for 
neuregulin 1. This gene was previously shown to be downregulated during osteogenic 
differentiation of mesenchymal stem cells (MSCs) by Wnt3a, indicating cross talk between 
ERBB3 and Wnt3a in MSCs osteoblastic differentiation via Wnt/B Catenin signalling (Jullien et al. 
2012). Thus, functions of some of the genes identified in our gene signature are relevant to 
osteo/odontogenic differentiation but further studies should explore their specific roles in DPCs. 
A connectivity mapping approach to identify drugs that could be repurposed for the differentiation 
of stem cells appears promising, however, the process currently has limitations. There is a 
paucity of publicly available microarray data for differentiating cells, especially a niche cell type 
such as DPCs. Another disadvantage is that microarray probe IDs have to be converted to 
GPL96 to be compatible with ssCMap. This can result in the loss of probes and could affect the 
range of compounds identified by ssCMap. Nevertheless, the connectivity mapping discovery of 
aspirin although unexpected, is highly relevant to a proposed potential clinical application in pulp 
capping. Aspirin is a drug commonly used for the treatment of pain and inflammation and as an 
antiplatelet agent (Fuster & Sweeny 2011). The mechanisms by which it produces these effects 
are varied, but are in part via inhibition of prostaglandin synthesis (Vane 1971) and of NF-κB 
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observed at high therapeutic doses. The current study demonstrated that aspirin at a low 
concentration of 0.05mM, which induced odontogenic differentiation, reduced the levels of 
inflammatory cytokines IL-6 and MMP-9 that are well documented biomarkers for pulpitis 
(Rechenberg et al. 2016, Zanini et al. 2017). The results also demonstrated that aspirin treatment 
has no effect on the angiogenic growth factors angiogenin and angiopoietin and the cytokines IL-
8 and IL-1β. These findings demonstrate a selective anti-inflammatory effect of aspirin at low 
concentration that merit further investigation.
Conclusion 
Connectivity mapping, a web based informatics method, was successfully used to identify aspirin 
as a candidate drug that could modulate the differentiation of DPCs. Aspirin was shown to induce 
odontogenic differentiation in DPCs in vitro and this together with its anti-inflammatory effects, 
make it a potential candidate for vital pulp therapies. Future work to investigate appropriate 
delivery methods for in vivo application is warranted.
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Figure Legends
Figure 1 The sscMap output for the signature genes outlined in Table 1. The map is a plot of the 
distribution of candidate compounds that may enhance (right side) or suppress (left side) the 
desired effect (osteo/odontogenesis). Significant candidates are above the green line with either 
enhancing (right hand side) or reducing (left hand side) effects. The green line is a pre-
determined threshold p-value calculated using 1/N where N is the number of reference datasets. 
In this case N is 3738 resulting in a p value of 0.0003, at which the green line is set. ASA 
corresponds to the dot above the green line (significant) on the right side (enhancer). The 
connection score for ASA was 3.583, the set score was 0.262 and the p value was 0.0002.
Figure 2 Graph showing molecular and cellular function analysis of the differentially expressed 
genes using Ingenuity Pathway Analysis (IPA). The minimum significance level scored as –log (p-
value) was calculated with Fisher’s exact test. The significance value associated with a function in 
global analysis is a measure for how likely it is that genes participate in that function.
Figure 3 Effect of ASA on DPCs viability and osteo/odontogenic differentiation: (A-C) MTT 
graphs showing that ASA has no effects on DPC viability at concentrations < 1mM during culture 
for 3 (A), 5 (B) and 7 (C) days. (D) DPCs treated with 0.05mM ASA or osteogenic media (OM) for 
14 days showed high ALP activity compared to non-treated cells. (E&F) DPCs showed evidence 
of mineralization in response to ASA and OM, which, was significantly higher than untreated cells. 
Expression of osteo/odontogenic genes after exposure to 0.05 mM ASA quantified by qPCR 
showed: (G) DMP1 gene expression increased after 24 hours; (H) Both DMP1 and DSPP gene 
expression increased after 7 days. Data represent mean+/- SD; *** p <0.001, ** p <0.01, * 
p<0.05, as determined by ANOVA with Bonferroni post hoc correction. Results represent an 
average of three independent experiments.
Figure 4 Effect of ASA treatment on cytokine release in ex vivo pulpitis model: pro-inflammatory 
cytokines IL-6, CCL21 and MMP-9 were significantly reduced in response to treatment with 
0.05mM ASA, while expression of the angiogenic factors angiogenin and angiopoietin 1 and 
cytokines, INF gamma, IL-Iβ, IL-8 was unchanged. Data represent mean+/- SD; *** p< 0.001, * p 
<0.05 as determined by ANOVA-test with Bonferroni post hoc correction. Results represent an 
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Table 1 DPCs osteo/odontogenic gene signature List of genes (1) upregulated and (-1) downregulated identified by differential expression analysis. Only these 11 
genes were ssCMAp compatible and therefore were used as the gene signature. 
GPL96_ID Gene Symbol Gene Title Fold change Fold Value P Value Conversion
204028_s_at RABGAP1 RAB GTPase activating protein 1 1.0507 0.071418426 0.00014075 +1
218319_at PELI1 Pellino homolog 1 (Drosophila) 1.173 0.23031762 0.000262363 +1
218040_at PRPF38B PRP38 pre-mRNA processing factor 38 (yeast) domain containing B 1.066 0.092466009 0.000326306 +1
219808_at SCLY selenocysteine lyase 1.051 0.071873327 0.000422738 +1
206497_at C7orf44 chromosome 7 open reading frame 44 1.058 0.0818744 0.000712191 +1
200027_at NARS asparaginyl-tRNA synthetase 1.044 0.062898243 0.000903409 +1
220359_s_at ARPP21 cAMP-regulated phosphoprotein, 21kDa 0.965 -0.051191504 0.000109973 -1
207399_at BFSP2 beaded filament structural protein 2, phakinin 0.862 -0.214114885 0.000396292 -1
208415_x_at ING1 inhibitor of growth family, member 1 0.915 -0.127681727 0.000494042 -1
202454_s_at ERBB3 v-erb-b2 erythroblastic leukaemia viral oncogene homolog 3 (avian) 0.9284 -0.1017104776 0.00059818 -1
204416_x_at APOC1 apolipoprotein C-I 0.9425 -0.085298083 0.00089721 -1
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